Kobo Biotech Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported net loss was INR 12.56 million compared to INR 17.93 million a year ago. Basic loss per share from continuing operations was INR 0.53 compared to INR 0.75 a year ago. Diluted loss per share from continuing operations was INR 0.53 compared to INR 0.75 a year ago.
For the full year, revenue was INR 0.152 million compared to INR 0.152 million a year ago. Net loss was INR 49.29 million compared to INR 55.53 million a year ago. Basic loss per share from continuing operations was INR 2.07 compared to INR 2.33 a year ago. Diluted loss per share from continuing operations was INR 2.07 compared to INR 2.33 a year ago.